Navigation Links
Aerovance Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma
Date:3/2/2009

BERKELEY, Calif., March 2 /PRNewswire/ -- Aerovance Inc. today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate Aerovance's Phase IIb clinical trial, AeroTrial(TM), of inhaled dry powder Aerovant in patients with uncontrolled asthma.

Study initiation begins today in the United States for AeroTrial, a double-blind, randomized, placebo-controlled, Phase IIb dose-ranging study. Aerovance expects to enroll approximately 500 patients with moderate to severe asthma, in the United States and Europe, who are poorly controlled by the combination of inhaled corticosteroids (ICS) and long-acting beta agonists (LABA). Patients will be randomly assigned to receive one of three Aerovant doses (1 mg, 3 mg or 10 mg) or placebo by inhalation twice daily for 12 weeks, during which time their standard ICS and LABA therapies will be gradually withdrawn. The primary endpoint is exacerbation incidence on Aerovant therapy as compared to placebo. Secondary endpoints include pulmonary function, time to exacerbation, daily peak expiratory flow (PEF) and symptom scores, immunoglobulin E (IgE) levels, and fractional concentration of expired nitric oxide (FeNO).

"Regulatory clearance and initiation of AeroTrial are significant milestones for Aerovance and potentially for patients living with uncontrolled asthma. The efficacy and safety data from our completed Aerovant studies are promising, and we are pleased to begin evaluation of this compound in a large number of moderate to severe asthmatics," said Mark Perry, Aerovance's president and chief executive officer. "Aerovant targets a root cause of asthma by blocking the signaling activity of two key cytokines, interleukin-4 (IL-4) and interleukin-13 (IL-13), critical in the progression of the disease. Our Phase IIa data suggest that targeted delivery to the lung is superior
'/>"/>

SOURCE Aerovance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Show Aerovances Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients
2. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
7. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
8. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. Prolexys Pharmaceuticals Initiates Phase 1 Study
11. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015 Contego Medical, ... Embolic Protection™ filter platform for angioplasty balloon and ... $5.6 million Series B financing round led by ... with a focus on medical devices, biopharmaceuticals, diagnostics ... also included Mountain Group Partners, Lookout Capital and ...
(Date:4/17/2015)... , April 17, 2015  AbbVie Inc. ("AbbVie") (NYSE ... that it has extended the expiration of its exchange offer ... of Pharmacyclics, Inc. to 5 p.m., New York ... On April 17, 2015, AbbVie also voluntarily withdrew its ... Act in order to provide the FTC with additional time ...
(Date:4/17/2015)... Inivata, a Cambridge, England -based ... the 2015 American Association for Cancer Research (AACR) Annual Meeting ... and a poster presentation. Michael Stocum , CEO ... nd . The presentation, entitled Monitoring the ... part of a session on Recent Advances in Diagnostics ...
Breaking Medicine Technology:Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 4Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2
... 12, 2011 PLC Systems Inc. (OTCBB: PLCSF), a ... it will demonstrate its innovative new product, RenalGuard®, at ... Percutaneous Cardiovascular Interventions (EAPCI).  More than 11,000 clinicians and ... attend this event, which will take place in Paris, ...
... PHOENIX, May 12, 2011 Altitude Organic Corporation (Pinksheets: ... publicly-traded medical marijuana company, is pleased to announce that ... dispensary owners in Arizona who wish to open their ... acts as a consultant to prospective dispensary owner-affiliates, is ...
Cached Medicine Technology:PLC to Demonstrate RenalGuard® at EuroPCR 2011 2PLC to Demonstrate RenalGuard® at EuroPCR 2011 3Altitude Organic Recruits 10 Arizona Dispensary Applicant Affiliates 2Altitude Organic Recruits 10 Arizona Dispensary Applicant Affiliates 3
(Date:4/17/2015)... April 17, 2015 As a board-certified ... his new offering of platelet-rich plasma (PRP) ... (MOSM) is known for its world-class care of ... extensive surgical experience lacking in many other physicians offering ... treatments are utilized for pain management and rehabilitation. Dr. ...
(Date:4/17/2015)... Most dental patients are not aware ... made overseas by foreign dental laboratories, according to the ... in more than 40 states by their respective state ... Dental Laboratories has created the “What’s In ... about the consequences that could be associated with using ...
(Date:4/17/2015)... Baptist Health and The University of ... agreement designed to transform oncology care in northeast Florida ... to create a joint cancer program to enhance patient ... Baptist MD Anderson Cancer Center is anticipated to open ... for highly coordinated, multidisciplinary cancer care for adults in ...
(Date:4/17/2015)... April 17, 2015 Scientists from ... multicenter team of U.S. and Venezuelan researchers, have ... in humans among an isolated tribe of Yanomami ... Bacterial diversity in the Yanomami, previously unexposed to ... nearly double that of people living in industrialized ...
(Date:4/17/2015)... TX (PRWEB) April 17, 2015 Connie ... specialist and functional medicine advocate with 30 years of ... will be adding another level of service for her ... her website of 10 recommended wellness books with a ... When asked to explain her interest in providing this ...
Breaking Medicine News(10 mins):Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 3Health News:National Association Urges Transparency in Dental Industry 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 2Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 3Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2
... HealthDay Reporter , WEDNESDAY, April 27 (HealthDay News) -- ... were also removed had a lower risk of subsequent ovarian ... or other types of cancer, a new study indicates. ... the researchers analyzed more than 25,000 postmenopausal women aged 50 ...
... HealthDay Reporter , WEDNESDAY, April 27 (HealthDay News) -- ... sugar control, often sending people with type 2 diabetes ... that happens. Now, a new study provides some ... decline dramatically in those who have the bypass surgery, ...
... -- Levels of chemical flame-retardants in the blood of pet ... researchers have found. In the study, Indiana University scientists ... blood of 17 pet dogs who mainly lived indoors. The ... about 2 nanograms per gram. The researchers also found ...
... Widespread demands in Canada for clinical trials for a controversial ... Internet and social media to influence research priorities, according to ... Zamboni, an Italian surgeon, suggested in 2008 that MS was ... by blockages in the brain. He proposed unblocking the veins ...
... , WEDNESDAY, April 27 (HealthDay News) -- Researchers in ... the activity of a single gene in living cells. ... University watched, in real time, the process of gene transcription ... gene converts its DNA information into molecules of messenger RNA ...
... WEDNESDAY, April 27 (HealthDay News) -- Doctors are far more ... an expensive MRI scan if they own or lease such ... School of Medicine researchers also found that after orthopedists bought ... back surgery within six months of seeing the orthopedist for ...
Cached Medicine News:Health News:Removing Ovaries During Hysterectomy Won't Raise Other Health Risks: Study 2Health News:Removing Ovaries During Hysterectomy Won't Raise Other Health Risks: Study 3Health News:New Clues to How Gastric Bypass Surgery Combats Diabetes 2Health News:New Clues to How Gastric Bypass Surgery Combats Diabetes 3Health News:Pet Dogs May Be Exposed to High Levels of Flame Retardants 2Health News:Social media can alter research priorities, according to paper in Nature 2Health News:Researchers Describe Gene Activity in Living Cells 2Health News:When Docs Own MRIs, Back Pain Scans Increase: Study 2Health News:When Docs Own MRIs, Back Pain Scans Increase: Study 3
Bottega Venetas new collection expresses a unique style and determined personality: discreet elegance and refined luxury are the themes that inspire the creation of these new models, destined to beco...
Classic, stylish, and preppy, this collection features men's, women's and unisex styles....
... the elegant and sophisticated woman, ... includes ophthalmic and sunwear styles. ... variety of shapes and colors, ... shapes and complexions. Many styles ...
The Nine West Eyewear collection is positioned to present today's styles with a sharp, edgy contemporary attitude tied into a clean design element....
Medicine Products: